Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Policlinico S.Orsola-Malpighi
Bolonia, ItaliaPublicacións en colaboración con investigadores/as de Policlinico S.Orsola-Malpighi (20)
2024
-
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer
Clinical Lung Cancer, Vol. 25, Núm. 3, pp. 233-243.e8
-
Molecular states associated with dysfunction and graft loss in heart transplants
Journal of Heart and Lung Transplantation, Vol. 43, Núm. 3, pp. 508-518
-
Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival
American Journal of Transplantation
2023
-
Impact of lymph node ratio and number of lymph node metastases on survival and recurrence in laryngeal squamous cell carcinoma
Head and Neck, Vol. 45, Núm. 9, pp. 2274-2293
-
Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology
European Journal of Heart Failure, Vol. 25, Núm. 4, pp. 457-468
2022
-
Assessing the Relationship Between Molecular Rejection and Parenchymal Injury in Heart Transplant Biopsies
Transplantation, Vol. 106, Núm. 11, pp. 2205-2216
-
Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology, Vol. 79, Núm. 20, pp. 1986-1997
-
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations
European Journal of Cancer
-
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations
European Journal of Cancer, Vol. 167, pp. 142-148
-
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator
European heart journal, Vol. 43, Núm. 32, pp. 3053-3067
-
Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study
Frontiers in Cardiovascular Medicine, Vol. 10
-
Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy
Circulation. Arrhythmia and electrophysiology, Vol. 15, Núm. 5, pp. e010075
-
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy
European Journal of Preventive Cardiology, Vol. 29, Núm. 4, pp. 645-653
2021
-
Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: The ESC EORP Cardiomyopathy/Myocarditis Registry
European Heart Journal Cardiovascular Imaging, Vol. 22, Núm. 7, pp. 781-789
-
Prospective follow-up in various subtypes of cardiomyopathies: Insights from the ESC EORP Cardiomyopathy Registry
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 7, Núm. 2, pp. 134-142
-
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging
Journal of Clinical Medicine, Vol. 10, Núm. 16
2020
-
Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European Registry
Circulation: Genomic and Precision Medicine, Vol. 13, Núm. 6, pp. E003117
-
Minimally Invasive Aortic Valve Replacement with Sutureless Valves: Results From an International Prospective Registry
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, Vol. 15, Núm. 2, pp. 120-130
2019
-
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)
JAMA Cardiology, Vol. 4, Núm. 9, pp. 918-927